DIA
Drug Information Association Logo
« Back to Listing

Big Data, Big Impact: New Levels of Strategic Partnerships Between Sponsors-CROs

Track:
Innovative Partnering Models and Outsourcing Strategies

Day & Time:
June 17, 8:00AM - 9:30AM (Pacific Standard Time)

Session Number:
206

Room Number:
3

Level:
Intermediate

Type:
Forum

Title:
Big Data, Big Impact: New Levels of Strategic Partnerships Between Sponsors-CROs

Chair(s):
MaryAnne Rizk, PhD, MSc
Global Head, CRO Business Partnerships
Oracle Health Sciences, United States

Description:
The big data transformation within life sciences has revolutionized collaborations and how strategic partnerships between CROs and sponsors are formed. This forum will show how to leverage the wealth of new data and improved analytics to enhance future innovation partnerships that will feed the drug development pipeline. Panelists will include speakers from both CROs and their sponsor partners addressing leading techniques to improve their productivity and efficiency in order to better demonstrate clinical benefit and health outcomes.

Learning Objective(s):
Discuss how unique levels of collaboration can broaden capabilities and insights to leverage new discovery technologies, integrate clinical trial efficiency, and raise new levels of true partnerships for innovation breakthroughs.

Presentation(s) & Speaker(s):
Panelist
Brendan M. Buckley, MD, PhD
Chief Medical Officer
ICON, Ireland

Panelist
Gary J. Thompson, MS
Senior Director, Data Sciences and Solutions
Eli Lilly and Company, United States

Panelist
MaryAnne Rizk, PhD, MSc
Global Head, CRO Business Partnerships
Oracle Health Sciences, United States